Åsa Riisberg

Åsa Riisberg is the current Director at Netcompany. Prior to their current role, they held positions at Patricia Industries, Chiesi Group, Internetmedicin, and Vifor Pharma. From May 2021 to August 2022, they served as a Board Member and Chairman of Audit Committee at Vifor Pharma, a specialty pharma company publicly listed in Switzerland. During their time at Vifor Pharma, the company divested to CSL for $11.7bn, representing the largest biopharma M&A deal in 2021. Prior to their role at Vifor Pharma, Riisberg held positions at Atlas Antibodies, Dagens Nyheter, Netcompany, Bonnier News, and Stockholm School of Economics.

Åsa Riisberg attended the Stockholm School of Economics and HEC Paris.